Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parrinello

Showing results (911-920 of 983) with videos related to

Pageof 99
Sort By:
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Frontiers in Oncology|March 6, 2019
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53Elena Tirrò, Michele Massimino, Chiara Romano, et al.
ACS Nano|November 5, 2016
Plasmonic Nanoprobes for Stimulated Emission Depletion NanoscopyEmiliano Cortés, Paloma A Huidobro, Hugo G Sinclair, et al.
Cancers|April 14, 2026
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune DysfunctionDaniela Cambria, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello, et al.
JAMA Cardiology|September 27, 2023
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020John W Ostrominski, Suzanne V Arnold, Javed Butler, et al.
Experimental Hematology|January 14, 2021
Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortalityGiuseppe Milone, Paola Scirè, Maria Grazia Camuglia, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib TreatmentGrazia Scandura, Cesarina Giallongo, Fabrizio Puglisi, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Plos One|September 27, 2013
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Giulio Marchesini, et al.
Pageof 99

Showing results (911-920 of 983) with videos related to

Sort By:
Pageof 99
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Frontiers in Oncology|March 6, 2019
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53Elena Tirrò, Michele Massimino, Chiara Romano, et al.
ACS Nano|November 5, 2016
Plasmonic Nanoprobes for Stimulated Emission Depletion NanoscopyEmiliano Cortés, Paloma A Huidobro, Hugo G Sinclair, et al.
Cancers|April 14, 2026
FcγRIIIA Genotype in Plasma Cell Dyscrasias Is Associated with Clinical Progression, Bone Disease Extension and Immune DysfunctionDaniela Cambria, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello, et al.
JAMA Cardiology|September 27, 2023
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020John W Ostrominski, Suzanne V Arnold, Javed Butler, et al.
Experimental Hematology|January 14, 2021
Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortalityGiuseppe Milone, Paola Scirè, Maria Grazia Camuglia, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib TreatmentGrazia Scandura, Cesarina Giallongo, Fabrizio Puglisi, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Plos One|September 27, 2013
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Giulio Marchesini, et al.
Pageof 99